Product Details
Product Details
Product Specification
| Species | Mouse |
| Antigen | OPN/SPP1 |
| Synonyms | BNSP, BSP-1 |
| Accession | Q547B5 |
| Amino Acid Sequence | Leu17-Asn294, with C-terminal 8*His |
| Expression System | HEK293 |
| Molecular Weight | 45-55kDa (Reducing) |
| Purity | >95% by SDS-PAGE |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, pH7.4 |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
| Reference |
1.Kung-Hao Liang. OPN sesame. Hepatobiliary Surg Nutr 2014;3(3):112-114. |
Background
OPN is an integrin-binding glycoprotein alsoknown as secreted phosphoprotein 1 (SPP1). OPN is so named because it was firstdiscovered in osteoblasts and osteoclasts. The latter is developed from themacrophage lineage. OPN protein has a secreted form and an intracellular form.The secreted OPN has two integrin-binding domains which can adhere to integrinson the surfaces of macrophages, making it a potent chemoattractant as well as anactivator of macrophages. In innate immunological cells such as dendriticcells, OPN can be activated upon infection. The OPN-integrin binding cantrigger downstream macrophage activities including TNF secretion, producing aninflammatory microenvironment. Poor prognosis of HCC was correlated withelevated OPN RNA, tissue OPN protein levels and pre-operative serum OPN proteinlevels. An anti-OPN antibody has been shown to defer the growth and metastasisof breast cancer in a mice model. As macrophages can also secret OPN, PTM andOPN form a vicious autocrine/paracrine cycle for the progression of cancer.Thus, in the future, novel strategies to break this cycle could bring to newanti-HCC treatments.
Picture
Picture
SDS-PAGE

